Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma

Por Bayraktar, Soley, Rocha-Lima, Caio M
Publicado em 2013

Erlotinib (Tarceva) for the Treatment of Non–Small-Cell Lung Cancer and Pancreatic Cancer

Por Rocha-Lima, Caio M., Raez, Luis E.
Publicado em 2009

Molecular basis and management of gastrointestinal stromal tumors

Por Bayraktar, Ulas D, Bayraktar, Soley, Rocha-Lima, Caio M
Publicado em 2010

Sustained response to FOLFOX and Bevacizumab in metastatic bronchial carcinoid – A case report and review of the literature

Por Akunyili, Ikechukwu, Garcia-Buitrago, Monica T, MacIntyre, Jessica, Levi, Joe, Rocha Lima, Caio M
Publicado em 2011

Severe colitis associated with docetaxel use: A report of four cases

Por Carrion, Andres F, Hosein, Peter J, Cooper, Eugene M, Lopes, Gilberto, Pelaez, Liset, Rocha-Lima, Caio M
Publicado em 2010

The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma

Por Palacio, Sofia, Hosein, Peter J., Reis, Isildinha, Akunyili, Ikechukwu I., Ernani, Vinicius, Pollack, Terri, Macintyre, Jessica, Restrepo, Maria H., Merchan, Jaime R., Rocha Lima, Caio M.
Publicado no J Gastrointest Oncol (2018)

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma

Por Hosein, Peter J, Macintyre, Jessica, Kawamura, Carolina, Maldonado, Jennifer Cudris, Ernani, Vinicius, Loaiza-Bonilla, Arturo, Narayanan, Govindarajan, Ribeiro, Afonso, Portelance, Lorraine, Merchan, Jaime R, Levi, Joe U, Rocha-Lima, Caio M
Publicado em 2012

A Phase 2 Trial of Ixabepilone Plus Cetuximab in First-Line Treatment of Metastatic Pancreatic Cancer

Por Rocha Lima, Caio M., Lin, Edward H., Kim, George P., Giguere, Jeffrey K., Marshall, John, Zalupski, Mark, Papageorgio, Chris, Auber, Miklos L., Kaleta, Remigiusz, McHenry, M. Brent, Trifan, Ovidiu C., Philip, Philip A.
Publicado em 2012